Sol Kim
AdvisorIntroduction
Ms. Sol Kim has been responsible for New Drug Pricing since 2012 in many multinational pharmaceutical companies, including Pfizer Korea, AstraZeneca Korea, and BMS Korea. With over a decade of experience in pricing, Ms. Kim has successfully achieved the pricing of multiple innovative drugs including Oncology and Rare disease drugs. Additionally, she has extensive experience in other areas of pharmaceutical business, including Medical Affairs, Marketing and Regional operations.
Ms. Kim holds pharmacist licenses in both Korea and New Zealand.
Areas of Expertise
Professional Career
- 2024-PresentShin & Kim LLC
- 2022-2024BMS Korea
- 2014-2022AstraZeneca Korea
- 2012-2013Pfizer Korea
Key Experience
New Drug Registration and Indication Expansion
- Treatment for non-small cell lung cancer
- Treatment for myelodysplastic syndrome
- Treatment for psoriasis
- Treatment for ulcerative colitis
- Treatment for multiple myeloma
- Treatments for breast cancer
- Treatments for ovarian cancer
- Treatments for osteoporosis
- Treatments for cardiovascular disease
Education
- 2013-2017Seoul National University Graduate School of Public Health (MPH)
- 2007-2010University of Otago College of Pharmacy (B.Pharm)
Qualifications
- 2014Licensed Pharmacist, Korea
- 2011Licensed Pharmacist, New Zealand
Languages
Korean, English